google stock price-Access our proprietary algorithm that analyzes 5,000+ data points to identify undervalued stocks with high growth potential. This tool is normally reserved for institutional clients..... 
In the ever-evolving world of the stock market, penny stocks have always been a popular choice for investors looking to make a big impact with a small investment. 2017 was no exception, with several penny stocks emerging as potential game-changers for those who knew where to look. This article will delve into the best US penny stocks to buy in 2017, providing you with valuable insights and analysis to make informed investment decisions.
Understanding Penny Stocks
Before we dive into the specifics, it's important to understand what penny stocks are. Penny stocks are shares of small, often under-the-radar companies that trade for less than $5 per share. These stocks are typically not followed by Wall Street analysts, making them ripe for discovery and potential growth.
Top Penny Stocks to Watch in 2017
Biohaven Pharmaceuticals Inc. (BHVN)
- Why it was a top pick: Biohaven Pharmaceuticals was a standout in the biotech sector, specializing in the development of treatments for neurological disorders. The company's innovative approach and promising pipeline made it a top pick for investors in 2017.
Ampion Pharmaceuticals Inc. (AMPE)
- Why it was a top pick: Ampion Pharmaceuticals focused on the development of treatments for osteoarthritis, a condition affecting millions of people worldwide. The company's potential to revolutionize the treatment of this common ailment made it an attractive investment opportunity.
CureVac N.V. (CVAC)
- Why it was a top pick: CureVac was a leader in the field of mRNA technology, a groundbreaking approach to vaccine development. The company's focus on creating effective and efficient vaccines made it a compelling investment choice in 2017.
Insys Therapeutics Inc. (INSY)
- Why it was a top pick: Insys Therapeutics specialized in the development of pharmaceuticals for the treatment of chronic pain. The company's innovative products and growing market presence made it a valuable investment opportunity.
Amarin Corporation plc (AMRN)
- Why it was a top pick: Amarin Corporation focused on the development of omega-3 fatty acid supplements, aiming to improve cardiovascular health. The company's commitment to research and development, along with a growing customer base, made it a top pick for investors.
Case Study: Biohaven Pharmaceuticals Inc. (BHVN)
One of the most notable penny stocks from 2017 was Biohaven Pharmaceuticals. The company's breakthrough drug, Tepezza, was approved by the FDA to treat hyperthyroidism. As a result, Biohaven's stock price skyrocketed, offering investors a significant return on their investment.
Conclusion
Investing in penny stocks can be a risky endeavor, but with the right research and strategy, it can also be highly rewarding. In 2017, several penny stocks emerged as potential winners, including Biohaven Pharmaceuticals, Ampion Pharmaceuticals, CureVac, Insys Therapeutics, and Amarin Corporation. By understanding the risks and opportunities associated with penny stocks, investors can make informed decisions and potentially capitalize on these investment opportunities.
us stock market today
